Breast cancer is one of the most frequently occurring female cancer types and represents a major cause of death among women worldwide. Breast cancer is heterogeneous in both molecular characteristics and clinical outcomes for its different molecular subtypes. High-throughput technologies facilitated the fast accumulations of the multiple Omic data for cancer patients. These data sources posed a computational challenge for the efficient integrated multi-Omic analysis. The existing studies usually investigated the differential representation or machine learning problems using a single type of Omic data. This study hypothesized that different Omic types contributed complementary information to each other, and their integrated analysis may improve the single-Omic models. An efficient logistic regression-based multi-Omic integrated analysis method (ELMO) was proposed to integrate the RNA-seq and DNA methylation data to detect the breast cancer intrinsic subtypes. ELMO achieved the highest accuracy with a smaller number of features compared with the existing filter and wrapper feature selection methods in this study. The experimental data supported our hypothesis that multi-Omic models outperformed the single-Omic ones.
The modern high-throughput technologies provided a unique opportunity to investigate the prognosis prediction of breast cancer from the multi-modality point of view [14] [15] [16] . The Cancer Genome Atlas (TCGA) was one of the most comprehensive cancer multi-OMIC datasets and described breast cancers by genomic variation, DNA methylation, exome sequencing, mRNA transcriptome, microRNA sequencing, and reverse-phase protein array, etc [3] .
This study hypothesized that the PAM50 transcriptomic panel may be improved by integrating multi-OMIC datasets. The RNA-seq and DNA-methylation data were explored to build a PAM50-subtype prediction model [17] , [18] . There were about 40,000 and 400,000 features for the two OMIC datasets RNA-seq and DNA-methylation, respectively, which were many more than the number of samples (about 500). Such a ''large p small n'' paradigm may be solved by reducing the number of features used by the prediction model [19] . A delicate four-step feature selection method, ELMO, was proposed to find a set of biomarkers with an accurate PAM50subtype prediction. ELMO extracted useful biomarkers from both of the two complementary Omic datasets and achieved an accurate PAM50-subtype prediction with only 42 features.
II. MATERIALS AND METHODS

A. SUMMARY OF DATASETS
This study extracted the RNA-seq, DNA methylation, and clinical diagnosis data from the TCGA database (release 11.0, May 21, 2018) [20] , [21] . The RNA-seq data was retrieved as the level-3 Illumina RNASeqV2 format, and the DNA methylation was generated by the Illumina HumanMethylation450 platform. The clinical data was also manually extracted from the TCGA database. The breast cancer intrinsic subtypes were defined by the PAM50 panel in the TCGA clinical data. The four intrinsic subtypes investigated in this study were luminal A, luminal B, HER2-enriched, and basal-like. There were 518 breast cancer samples with all the three data types, i.e., RNA-seq, DNA methylation, and intrinsic subtype. The four subtypes luminal A, luminal B, HER2enriched and basal-like were abbreviated as luminalA, lumi-nalB, HER2 and basal, respectively. There were 276, 126, 31, and 85 samples for the four subtypes.
B. DATA PREPROCESSING
The raw data were pre-processed by the following procedures. Features in the RNA-seq data were removed if they had minor variances using the nearZeroVar function in the R package caret using the default parameters [22] . The DNA methylation data were pre-processed by a three-step procedure as similar in the other studies [19] , [23] . Firstly, samples or features were removed if they had more than 20% missing data. Secondly, The remaining missing data were imputed using the function impute() in the R package impute [24] . Thirdly, the remaining data were normalized using z-score.
After the above-mentioned pre-processing procedures, this study used 518 samples, and each sample had 43,805 RNA-seq features and 395,574 DNA methylation features, respectively.
C. PERFORMANCE MEASUREMENTS OF THE PREDICTION MODELS
This study investigated a four-class classification problem, with the class labels luminalA, luminalB, HER2, and basal. The proposed algorithm ELMO was compared with the other feature selection algorithms for the prediction accuracies of the same classifier using their chosen features.
After a feature selection method selected a subset of features based on the complete dataset, this study evaluated a classifier's prediction accuracy by averaging 20 random runs of the 10-fold cross-validations of a given feature subset. Under the 10-fold cross-validation strategy, the data were divided into 10 folds with approximately the same size. Then an iterative experiment was carried out that a classifier was trained on 9 folds and validated for its prediction performance on the remaining one-fold. This process was repeated for all 10 folds, and then the averaged values of these classification performance metrics were calculated as the final results.
The prediction accuracy of a classifier was defined as the percentage of the correctly predicted samples. In order to eliminate the algorithmic bias of the classifiers, seven classifiers were evaluated, and the maximal value of their accuracies was defined as the performance measurement mAcc of a given feature subset, as similar in [25] [26] [27] . The seven classifiers were support vector machine (SVM) [28] , naïve bayes (NB) [29] , decision tree (DT) [30] , k-nearest neighbor (KNN) [31] , logistic regression (LR) [32] , gradient boosted decision tree (GBDT) [33] , [34] and xgboost (XGB) [35] .
D. MULTI-OMIC DATA INTEGRATION METHODS
Multi-Omic data integration methods may be summarized into three main categories, i.e., early, intermediate, and late integration [36] . The easiest way is to directly combine these data, which is called the early integration method [19] , [36] . The intermediate method integrates the multi-Omic data during the learning process. Moreover, the late integration method builds a model for each Omic data source and then these models' prediction results were aggregated to form the final prediction results.
The late integration method was similar to an ensemble learning method, and the majority voting result was the most widely used strategy in the ensemble method [19] , [36] . A simple majority voting was based on at least three voters to avoid the challenge of two conflicting voters. This study investigated only two OMIC data sources for the integrated analysis, so the late integration method was not evaluated.
The following sections evaluated the early and intermediate data integration methods. Figure 1 illustrated the pseudo-code of the proposed algorithm ELMO. Firstly, features with the zero weights were removed from further analysis after the L1 regularized LR model was trained. Due to that the number of features was significantly larger than that of the samples in the multi-Omic dataset, a step of dimension reduction was necessary. The early integration method combined the RNA-seq and DNA-methylation data and then the L1-regularization was applied. While the intermediate integration method ran the L1-regularization on each Omic data and then combined the features with non-zero weights. Details may be found in Figure 1 .
E. THE PROPOSED ALGORITHM ELMO
F. TWO GROUPS OF FEATURE SELECTION ALGORITHMS
A comprehensive comparative study was carried out to evaluate how ELMO performed on the prediction model of the breast cancer subtyping problem, as shown in Figure 2 .
This work aims at proposing a novel multi-omics integrated method ELMO, and it was compared with eight filters and eleven wrappers in this study. The eight filter algorithms were t-test (Ttest) [37] , Wilcoxon test (Wtest) [38] , mutual information (MI) [39] , false discovery rate (FDR) [40] , ReliefF [41] , Spearman's correlation coefficient (Spearman), information gain (IG) and symmetrical uncertainty (SU) [42] . A filter assumed that features were independent to each other and the features may be evaluated each feature individually. All the features were then ranked and the top-k features with the best prediction accuracy was kept for further analysis.
Eleven wrapper algorithms were also evaluated for their prediction accuracies of the four-class classification problem. Two L1-regularized classifiers, L1-regularized logistic regression (L1-LR) [43] and L1-regularized linear SVM (L1-SVM) [44] were utilized to subtype breast cancers in this study. Recursive feature elimination (RFE) was a widelyused feature selection framework [45] that may use different classifiers as the feature evaluator, e.g., support vector machine (SVM-RFE) [46] , decision tree (DT-RFE) and logistic regression (LR-RFE), etc. Other investigated wrappers were extremely randomized tree (ET) [47] , gradient boosted decision tree (GBDT), xgboost (XGB), random forest (RF) [48] , McTwo [27] and RIFS [26] .
All the programs were coded in Python version 3.6. Reli-efF, IG and SU were implemented in the library skfeature [49] . Ttest, Wtest and Spearman were from the library SciPy, and the other algorithms were provided in the library scikitlearn.
This study employed the one-vs-rest strategy to formulate the four-class classification problem as multiple binary classification problems. Many of the existing feature selection algorithms were originally designed for binary classification models. The final list of features was the union of the algorithm-selected features from these multiple binary classification problems. The incremental feature selection (IFS) strategy was employed to find the optimal number of features for the filters and the three RFE-based algorithms (SVM-RFE, DT-RFE and LR-RFE). Default parameters were used for all the feature selection algorithms in the individual python libraries, which may be found in the python manual.
III. RESULTS AND DISCUSSION
A. ELMO'S INCREMENTAL FEATURE SELECTION PROCEDURE
The proposed algorithm ELMO used the incremental feature selection (IFS) strategy to find the best number of features after the L1-regularized LR was used to remove the features with zero L1-weights. Firstly, the LR-RFE was used to rank the features by the LR weights. Then the IFS strategy evaluated the top-k ranked features by the prediction accuracy averaged over the 20 random runs of the 10-fold crossvalidations of the classifier LR. This study tried to improve the PAM50 panel. So the maximal number of selected features was set to 50.
The IFS curves over different datasets were illustrated in Figure 3 . Both the Intermediate integration and the Early integration strategies outperformed the models on single Omic data using more than 23 features. The model on the DNA methylation dataset performed the worst in most cases, which may be due to that more methylation residue features were needed to improve the model [25] . The best models on the single Omic dataset achieved 0.9852 ± 0.0166 and 0.9789 ± 0.0197 in mAcc using 49 RNA-seq and 48 DNA methylation features. The Early integration strategy achieved mAcc = 0.9908 ± 0.0134 using 19 RNA-seq and 26 DNA methylation features. While the Intermediate integration strategy used 22 RNA-seq and 28 DNA methylation features to achieve mAcc = 0.9973 ± 0.0067. All the best models were trained by the classifier LR compared against the other six classifiers.
Some other popular feature selection algorithms were not evaluated in this study. The algorithm mRMR was widely used to detect a feature subset for bioinformatics problems [14] . This study evaluated the algorithm mRMR implemented in the Python library skfeature and the RNA-Seq dataset has 43,805 features. The algorithm mRMR ran for more than six hours in our Inspur Gene Server G100 (256GB memory and 28 Intel Xeon 2.4GHz CPU cores). Another popular algorithm DESeq was designed for the count data from the highthroughput sequencing assays such as RNA-Seq and ChIP-Seq and may not be used for the FPKM-based transcriptomes in this study [50] , [51] .
B. SEQUENTIAL BACKWARD SELECTION (SBS) TO FURTHER IMPROVE ELMO
The modified SBS strategy was utilized to further reduce the number of features selected by ELMO, as shown in Figure 4 . Each feature subset was evaluated for its prediction accuracy averaged over the 20 random runs of the 10-fold crossvalidation strategy of the classifier LR. The modified SBS strategy in this study eliminated one or two features with the maximal improved accuracy, which is different from the classic version of the SBS framework [52] , [53] .
Four types of datasets were evaluated for the best solution. The best prediction accuracies were achieved by 41 or 42 features for all the four datasets, as shown in Figure 4 . The SBS strategy recommended 41 features to achieve 0.9898 ± 0.0131 in mAcc for the RNA-seq dataset (Figure 4 (a) ). While the best model by the DNA methylation dataset alone achieved mAcc = 0.9815 ± 0.0190 with only 42 features (Figure 4 (b) ). The Intermediate integration strategy performed the best (1.0000 ± 0.0000 in mAcc) using 20 RNAseq features and 22 DNA methylation features (Figure 4 (c)). The Early integration strategy performed slightly worse (0.9953 ± 0.0097 in mAcc) using 18 RNA-seq features and 23 DNA methylation features (Figure 4 (d) ). Among the seven utilized classifiers, LR performed the best on the SBSselected features.
The above experimental data suggested that the integrated analysis of the two Omic datasets outperformed the individual Omic dataset in many cases, as shown in Figures 3 and 4 . The Intermediate integration strategy performed better than the Early integration and this suggested that the individual Omic datasets may be pre-processed separately before their integrations. This data supported the observation that the direct combination of multiple Omic datasets may dilute the already low signal-to-noise ratio in each Omic dataset [19] .
C. COMPARISON WITH THE FILTER FEATURE SELECTION ALGORITHMS
ELMO was compared with 8 filter feature selection algorithms for their prediction performance mAcc averaged over the 20 random runs of 10-fold cross-validations. Filters only ranked features by various metrics and the IFS strategy was utilized to determine the number of features. As described above, this study only investigated the number of features no more than 50. Most of the existing feature selection algorithms were designed for the single-Omic data [54] . To compare with single-Omics data-based feature selection algorithms fairly, the comparative experiments focused on the individual Omic datasets and the Early integration dataset [55] , i.e., the two Omic datasets were combined as one for further analysis. Figure 5 illustrated that most filters only achieved mAcc < 0.8500 except for a few cases, while ELMO achieved at least 0.9800 with 41 or 42 features and the same classifier LR. Figure 5 (a) suggested that the filters MI and FDR selected RNA-seq features with better prediction mAcc than the other filters after the number of features reached 11. The classifier GBDT performed the best on the MI-selected RNA-seq features, while LR performed the best on the FDRselected features. All the 8 filters selected DNA methylation features with mAcc < 0.8200, suggesting that filters may have missed important inter-feature information, as shown in Figure 5 (b). Only minor improvements were observed for the 8 filters on the combination of both RNA-seq and DNA methylation datasets ( Figure 5 (c) ). So ELMO outperformed the 8 filters in most cases.
D. COMPARISON WITH THE WRAPPER FEATURE SELECTION ALGORITHMS
In Table 1 , three datasets were evaluated, i.e., RNA-Seq, DNA methylation, and Early integration. Column ''FS'' was the wrapper feature selection algorithm, and column ''F#'' was the number of features selected by this algorithm. Columns ''mAcc'' and ''Std'' gave the maximal Accuracy and standard deviation of the accuracies achieved by the seven evaluated classifiers. Column mCLF was the classifier achieving the maximum accuracy. All the feature selection algorithms and classifiers were evaluated with the default parameter values in the corresponding python libraries, which may be found in the python manual. The prediction accuracy of each classifier was calculated as the averaged accuracy of 20 random runs of the 10-fold cross-validation strategy of this classifier. The validation set was iteratively selected from the 10 randomly split subset, and the details may be found in the section ''Materials and Methods''.
ELMO was further compared with the 11 wrapper feature selection algorithms, as shown in Table 1 . The LR model using the L1-SVM achieved the best mAcc 0.9934, 0.9856, and 0.9983 for the three datasets RNA-seq, DNA methylation, and Early integration, respectively. But L1-SVM selected 589, 863 and 678 features from these three datasets. This study tried to improve the PAM50 panel on subtyping breast cancers and preferred the number of features smaller than 50. ELMO achieved a slightly worse mAcc (0.9898, 0.9815 and 0.9953 for the three datasets) using much smaller numbers of features (41-42 features). It's interesting to observe that the classifier LR performed the best on the features selected by both of the top two ranked feature selection algorithms L1-SVM and ELMO. And ELMO outperformed the algorithms selecting fewer features by at least 0.0452 in mAcc.
E. BIOLOGICAL FUNCTION ANALYSIS OF THE ELMO SELECTED MULTI-OMICS FEATURES
In Table 2 , there were 20 RNA-seq features and 22 DNA methylation features. Gene symbols for these RNA-seq and VOLUME 8, 2020 DNA methylation features were given in the two ''Gene'' columns.
These features were selected by ELMO on all the samples and screened for their biological functions by searching in the literature database PubMed [56] . The selected features cover all cancer hallmarks, including sustained cell proliferation, metastasis and drug resistance, genome instability and DNA damage response, tumor-promoting inflammation and immune response, as well as reprogrammed metabolism. For instance, as a canonical pathway controlling cell proliferation, MAPK signaling has been associated with several of these features such as ANO1 that is a component of Ca 2+ -activated CL − channels and causes malignant transformation once activated [57] .
Another kinase MAP2K6 that participates in MAPK signaling and is predictive of radio resistance in nasopharyngeal carcinoma cells on over-expression [58] . Several ELMOdetected biomarkers have known roles in tumor metastasis and drug resistance. CUX1 activates Wnt/beta-catenin signaling and EMT in breast cancers [59] . The helicaselike transcription factor HLTF suppresses the migration and invasion of colorectal cancers via TGF-beta/SMAD pathway and is a known target for methylation and epigenetic gene silencing [60] . The actin filament-associated protein AFAP1 codes for a motor fiber-related protein that alters actin filament integrity and participates in tumor invasion and metastasis [61] . LOX encodes an extracellular cuproenzyme that facilitates cancer metastasis through modifying the extracellular matrix (ECM) [62] . And AFF3 over-expression conferred Tamoxifen resistance in breast cancers [63] .
Multiple genes are involved in genome stability government and/or affect cell sensitivity to drug resistance. RECQL4 encodes a member of RECQ helicase family with DNA unwinding activity that plays an important role in maintaining genomic stability [64] and sensitizes breast cancer cells to DNA damaging agents [65] . ESPL1 is a putative oncogene of luminal B breast cancers that is associated with genomic profiles and molecular features of chromosomal instability [66] . PARP2 plays dual roles in DN damage response as sensors and signal transducers to downstream effectors, with specific functions in genome surveillance and DNA repair [67] . DDIAS, namely DNA damage-induced apoptosis suppressor, is responsible for cisplatin resistance in lung cancers [68] .
A few genes are also involved in inflammation and immune relevant signalings. NOD1 modulated pro-inflammatory pathways such as NFkB and MAPK [69] and was implicated as a tumor suppressor in ER-dependent breast cancers [70] . ITGAE defined CD8+ tumor-infiltrating lymphocytes and was proposed as a promising biomarker for rapid identification of immune infiltration in colorectal cancers [71] . As one emerging cancer hallmark, deregulated cellular energetics has recently been associated with Fenton effect. Tumors consecutively pump protons into cells to neutralize the rapidly increased OH-levels caused by the Fenton effect, which was considered one driving force of tumorigenesis and therapeutic resistance [72] , an ATP6V0C, being an ATP-driven proton pump, translocates protons from the cytoplasm into intracellular compartments [73] .
These ELMO-detected biomarkers and the hallmarks they represented do not function alone and collectively orchestrate the heterogeneity of breast cancers. For instance, the functionalities of PARK2 have been implicated in several cellular processes regulating cell growth and survival, mitochondria homeostasis and metabolism, as well as protein turnover and stress response [74] . On the other hand, these features may be collapsed to the differential cancer stemness each breast cancer subtype harbors that could be used to explain breast cancer complexities. For example, SPC25 over-expression was proposed to increase cancer stem cell properties in nonsmall cell lung adenocarcinoma cells and be prognostic of poor patient survival [75] ; and GRB7 encodes an intracellular signaling protein with significant functionalities in cancer cell migration and was identified as a therapeutic target for the treatment of multiple highly malignant tumors including HER2+ and TNBCs [76] . The Cox proportional-hazards model [78] is a commonly used statistical method in biomedical studies to evaluate the association between the survival time of patients and selected variables [79] [80] [81] [82] [83] . A risk score was calculated using the Cox proportional-hazards model, and patients with shorter survival times has larger risk scores [83] .
In this study, a survival analysis was performed using all the samples in the dataset. A multivariate Cox regression was performed using 42 features selected by ELMO using intermediate integration method. Then calculate a 42 features-based survival risk score for each sample. Using the median of the calculated risk scores as the cutoff value, the samples were divided into high-risk group and lowrisk group [81] , [83] . Overall survival curves were generated using the Kaplan-Meier method [84] , and the significance between two groups was estimated with the log-rank test. As shown in Figure 6 , samples in high-risk group had significantly poorer survival than samples in low-risk (log-rank p value = 1E-05 < 0.0001). The prognostic performance of these 42 features was estimated using time-dependent receiver operating characteristic (ROC) curves and area under the curves (AUCs). As shown in Figure 7 , the AUC of these 42 features for predicting five-year overall survival rate was 0.742.
IV. CONCLUSION
This study investigated the breast cancer subtyping problem using the multi-Omic datasets. The experimental data suggested that the two Omic datasets RNA-seq and DNA methylation achieved reasonable subtyping accuracies, and the integrated models performed better with fewer features. The proposed feature selection algorithm ELMO achieved 1.0000 in maximal accuracies using seven classifiers and 42 features. Compared with the 50 genes in the existing PAM50 subtyping panel, the proposed model used only 20 RNA-seq features and 22 DNA methylation features. ELMO also outperformed the existing 8 filter and 11 wrapper feature selection algorithms.
The detected 42 biomarkers demonstrated functional associations with different subtypes of breast cancers and good prognosis prediction performance. An experimental study may be necessary to further evaluate the scalability of the proposed biomarkers and the subtyping model.
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